{"count": 25, "results": [{"_id": "32327421", "pmid": 32327421, "pmcid": "PMC7305006", "title": "Hospitalization for Lactic Acidosis Among Patients With Reduced Kidney Function Treated With Metformin or Sulfonylureas", "journal": "Diabetes Care", "authors": ["Chu PY", "Hackstadt AJ", "Chipman J", "Griffin MR", "Hung AM", "Greevy RA Jr", "Grijalva CG", "Elasy T", "Roumie CL"], "date": "2020-07-01T00:00:00Z", "doi": "10.2337/dc19-2391", "meta_date_publication": "2020 Jul", "meta_volume": "43", "meta_issue": "7", "meta_pages": "1462-1470", "score": 50271.867, "text_hl": "Hospitalization for @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@Lactic Acidosis@@@ Among @SPECIES_9606 @@@Patients@@@ With @<m>DISEASE_Kidney_Neoplasms</m> @DISEASE_MESH:D007680 @@@Reduced Kidney Function@@@ Treated With @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ or @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@Sulfonylureas@@@", "citations": {"NLM": "Chu PY, Hackstadt AJ, Chipman J, Griffin MR, Hung AM, Greevy RA Jr, Grijalva CG, Elasy T, Roumie CL. Hospitalization for Lactic Acidosis Among Patients With Reduced Kidney Function Treated With Metformin or Sulfonylureas Diabetes Care. 2020 Jul;43(7):1462-1470. PMID: 32327421", "BibTeX": "@article{32327421, title={Hospitalization for Lactic Acidosis Among Patients With Reduced Kidney Function Treated With Metformin or Sulfonylureas}, author={Chu PY and Hackstadt AJ and Chipman J and Griffin MR and Hung AM and Greevy RA Jr and Grijalva CG and Elasy T and Roumie CL}, journal={Diabetes Care}, volume={43}, number={7}, pages={1462-1470}}"}}, {"_id": "34660791", "pmid": 34660791, "pmcid": "PMC8519697", "title": "The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis", "journal": "Biomed Res Int", "authors": ["Yao X", "Liu H", "Xu H"], "date": "2021-10-08T00:00:00Z", "doi": "10.1155/2021/5311828", "meta_date_publication": "2021", "meta_volume": "2021", "meta_issue": "", "meta_pages": "5311828", "score": 50270.85, "text_hl": "For @<m>DISEASE_Kidney_Neoplasms</m> @DISEASE_MESH:D007680 @@@kidney cancer@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ was beneficial for progression (HR = 0.80; 95% CI: 0.65-0.98; P = 0.14; I2 = 46%). ", "citations": {"NLM": "Yao X, Liu H, Xu H. The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis Biomed Res Int. 2021;2021():5311828. PMID: 34660791", "BibTeX": "@article{34660791, title={The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis}, author={Yao X and Liu H and Xu H}, journal={Biomed Res Int}, volume={2021}, pages={5311828}}"}}, {"_id": "35872697", "pmid": 35872697, "pmcid": "PMC9307380", "title": "A Randomized Study on the Effect of Metformin Combined with Intensive-Exercise Diet Therapy on Glucose and Lipid Metabolism and Islet Function in Patients with Renal Cell Carcinoma and Diabetes", "journal": "Dis Markers", "authors": ["Liu Y", "Meng LL", "Li JW", "Jin YS", "An RH"], "date": "2022-07-15T00:00:00Z", "doi": "10.1155/2022/7383745", "meta_date_publication": "2022", "meta_volume": "2022", "meta_issue": "", "meta_pages": "7383745", "score": 50268.84, "text_hl": "Accordingly, this study adopted @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ combined with exercise and diet therapy for @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Kidney_Neoplasms</m> @DISEASE_MESH:D007680 @@@renal cancer@@@ and @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ and gained desirable outcomes. ", "citations": {"NLM": "Liu Y, Meng LL, Li JW, Jin YS, An RH. A Randomized Study on the Effect of Metformin Combined with Intensive-Exercise Diet Therapy on Glucose and Lipid Metabolism and Islet Function in Patients with Renal Cell Carcinoma and Diabetes Dis Markers. 2022;2022():7383745. PMID: 35872697", "BibTeX": "@article{35872697, title={A Randomized Study on the Effect of Metformin Combined with Intensive-Exercise Diet Therapy on Glucose and Lipid Metabolism and Islet Function in Patients with Renal Cell Carcinoma and Diabetes}, author={Liu Y and Meng LL and Li JW and Jin YS and An RH}, journal={Dis Markers}, volume={2022}, pages={7383745}}"}}, {"_id": "33600406", "pmid": 33600406, "pmcid": "PMC7891741", "title": "Metformin doses to ensure efficacy and safety in patients with reduced kidney function", "journal": "PLoS One", "authors": ["Kuan IHS", "Wilson LC", "Leishman JC", "Cosgrove S", "Walker RJ", "Putt TL", "Schollum JBW", "Wright DFB"], "date": "2021-02-18T00:00:00Z", "doi": "10.1371/journal.pone.0246247", "meta_date_publication": "2021", "meta_volume": "16", "meta_issue": "2", "meta_pages": "e0246247", "score": 50268.19, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ doses to ensure efficacy and safety in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Kidney_Neoplasms</m> @DISEASE_MESH:D007680 @@@reduced kidney function@@@", "citations": {"NLM": "Kuan IHS, Wilson LC, Leishman JC, Cosgrove S, Walker RJ, Putt TL, Schollum JBW, Wright DFB. Metformin doses to ensure efficacy and safety in patients with reduced kidney function PLoS One. 2021;16(2):e0246247. PMID: 33600406", "BibTeX": "@article{33600406, title={Metformin doses to ensure efficacy and safety in patients with reduced kidney function}, author={Kuan IHS and Wilson LC and Leishman JC and Cosgrove S and Walker RJ and Putt TL and Schollum JBW and Wright DFB}, journal={PLoS One}, volume={16}, number={2}, pages={e0246247}}"}}, {"_id": "36720491", "pmid": 36720491, "pmcid": "PMC9894655", "title": "Comparative effectiveness of metformin versus sulfonylureas on kidney function decline or death among patients with reduced kidney function: a retrospective cohort study", "journal": "CMAJ Open", "authors": ["Hung AM", "Hackstadt AJ", "Griffin MR", "Grijalva CG", "Greevy RA Jr", "Roumie CL"], "date": "2023-01-31T00:00:00Z", "doi": "10.9778/cmajo.20210207", "meta_date_publication": "2023 Jan-Feb", "meta_volume": "11", "meta_issue": "1", "meta_pages": "E77-E89", "score": 50265.957, "text_hl": "Comparative effectiveness of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ versus @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@sulfonylureas@@@ on @<m>DISEASE_Kidney_Neoplasms</m> @DISEASE_MESH:D007680 @@@kidney function decline@@@ or @DISEASE_Death @DISEASE_MESH:D003643 @@@death@@@ among @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Kidney_Neoplasms</m> @DISEASE_MESH:D007680 @@@reduced kidney function@@@: a retrospective cohort study", "citations": {"NLM": "Hung AM, Hackstadt AJ, Griffin MR, Grijalva CG, Greevy RA Jr, Roumie CL. Comparative effectiveness of metformin versus sulfonylureas on kidney function decline or death among patients with reduced kidney function: a retrospective cohort study CMAJ Open. 2023 Jan-Feb;11(1):E77-E89. PMID: 36720491", "BibTeX": "@article{36720491, title={Comparative effectiveness of metformin versus sulfonylureas on kidney function decline or death among patients with reduced kidney function: a retrospective cohort study}, author={Hung AM and Hackstadt AJ and Griffin MR and Grijalva CG and Greevy RA Jr and Roumie CL}, journal={CMAJ Open}, volume={11}, number={1}, pages={E77-E89}}"}}, {"_id": "32342709", "pmid": 32342709, "title": "Increased kidney cancer risk in diabetes mellitus patients: a population-based cohort study in Lithuania.", "journal": "Aging Male", "authors": ["Undzyte G", "Patasius A", "Linkeviciute-Ulinskiene D", "Zabuliene L", "Stukas R", "Dulskas A", "Smailyte G"], "date": "2020-12-01T00:00:00Z", "doi": "10.1080/13685538.2020.1755249", "meta_date_publication": "2020 Dec", "meta_volume": "23", "meta_issue": "5", "meta_pages": "1241-1245", "score": 50254.254, "text_hl": "The objective of this study was to evaluate the association between T2DM with or without @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use and the risk of @<m>DISEASE_Kidney_Neoplasms</m> @DISEASE_MESH:D007680 @@@kidney cancer@@@ in a population-based national cohort in Lithuania. ", "citations": {"NLM": "Undzyte G, Patasius A, Linkeviciute-Ulinskiene D, Zabuliene L, Stukas R, Dulskas A, Smailyte G. Increased kidney cancer risk in diabetes mellitus patients: a population-based cohort study in Lithuania. Aging Male. 2020 Dec;23(5):1241-1245. PMID: 32342709", "BibTeX": "@article{32342709, title={Increased kidney cancer risk in diabetes mellitus patients: a population-based cohort study in Lithuania.}, author={Undzyte G and Patasius A and Linkeviciute-Ulinskiene D and Zabuliene L and Stukas R and Dulskas A and Smailyte G}, journal={Aging Male}, volume={23}, number={5}, pages={1241-1245}}"}}, {"_id": "33821674", "pmid": 33821674, "pmcid": "PMC8174186", "title": "Hospitalization for Heart Failure Among Patients With Diabetes Mellitus and Reduced Kidney Function Treated With Metformin Versus Sulfonylureas: A Retrospective Cohort Study", "journal": "J Am Heart Assoc", "authors": ["Richardson TL Jr", "Hackstadt AJ", "Hung AM", "Greevy RA", "Grijalva CG", "Griffin MR", "Elasy TA", "Roumie CL"], "date": "2021-04-06T00:00:00Z", "doi": "10.1161/JAHA.120.019211", "meta_date_publication": "2021 Apr 6", "meta_volume": "10", "meta_issue": "8", "meta_pages": "e019211", "score": 50253.3, "text_hl": "...Persistent use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ after @<m>DISEASE_Kidney_Neoplasms</m> @DISEASE_MESH:D007680 @@@kidney function decline@@@ is associated with reduced risk of @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@heart failure@@@ hospitalizations compared with sulfonylurea drugs.", "citations": {"NLM": "Richardson TL Jr, Hackstadt AJ, Hung AM, Greevy RA, Grijalva CG, Griffin MR, Elasy TA, Roumie CL. Hospitalization for Heart Failure Among Patients With Diabetes Mellitus and Reduced Kidney Function Treated With Metformin Versus Sulfonylureas: A Retrospective Cohort Study J Am Heart Assoc. 2021 Apr 6;10(8):e019211. PMID: 33821674", "BibTeX": "@article{33821674, title={Hospitalization for Heart Failure Among Patients With Diabetes Mellitus and Reduced Kidney Function Treated With Metformin Versus Sulfonylureas: A Retrospective Cohort Study}, author={Richardson TL Jr and Hackstadt AJ and Hung AM and Greevy RA and Grijalva CG and Griffin MR and Elasy TA and Roumie CL}, journal={J Am Heart Assoc}, volume={10}, number={8}, pages={e019211}}"}}, {"_id": "35271933", "pmid": 35271933, "title": "Progression of established non-diabetic chronic kidney disease is halted by metformin treatment in rats.", "journal": "Kidney Int", "authors": ["Corremans R", "Neven E", "Maudsley S", "Leysen H", "De Broe ME", "D'Haese PC", "Vervaet BA", "Verhulst A"], "date": "2022-05-01T00:00:00Z", "doi": "10.1016/j.kint.2022.01.037", "meta_date_publication": "2022 May", "meta_volume": "101", "meta_issue": "5", "meta_pages": "929-944", "score": 50245.543, "text_hl": "Chronic @CHEMICAL_Adenine @CHEMICAL_MESH:D000225 @@@adenine@@@ dosing resulted in severe @DISEASE_Renal_Insufficiency_Chronic @DISEASE_MESH:D051436 @@@CKD@@@ in vehicle-treated @SPECIES_10116 @@@rats@@@ as indicated by a marked rise in serum @CHEMICAL_Creatinine @CHEMICAL_MESH:D003404 @@@creatinine@@@ levels, a marked decrease in @CHEMICAL_Creatinine @CHEMICAL_MESH:D003404 @@@creatinine@@@ clearance, and a disturbed mineral metabolism. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, but not @CHEMICAL_Canagliflozin @CHEMICAL_MESH:D000068896 @@@canagliflozin@@@, halted @<m>DISEASE_Kidney_Neoplasms</m> @DISEASE_MESH:D007680 @@@functional kidney decline@@@. ", "citations": {"NLM": "Corremans R, Neven E, Maudsley S, Leysen H, De Broe ME, D'Haese PC, Vervaet BA, Verhulst A. Progression of established non-diabetic chronic kidney disease is halted by metformin treatment in rats. Kidney Int. 2022 May;101(5):929-944. PMID: 35271933", "BibTeX": "@article{35271933, title={Progression of established non-diabetic chronic kidney disease is halted by metformin treatment in rats.}, author={Corremans R and Neven E and Maudsley S and Leysen H and De Broe ME and D'Haese PC and Vervaet BA and Verhulst A}, journal={Kidney Int}, volume={101}, number={5}, pages={929-944}}"}}, {"_id": "32756091", "pmid": 32756091, "pmcid": "PMC7402713", "title": "A randomized controlled clinical trial study protocol of Liuwei Dihuang pills in the adjuvant treatment of diabetic kidney disease", "journal": "Medicine (Baltimore)", "authors": ["Liao T", "Zhao K", "Huang Q", "Tang S", "Chen K", "Xie C", "Zhang C", "Gan W"], "date": "2020-07-31T00:00:00Z", "doi": "10.1097/MD.0000000000021137", "meta_date_publication": "2020 Jul 31", "meta_volume": "99", "meta_issue": "31", "meta_pages": "e21137", "score": 50228.17, "text_hl": "Based on TCM theory and clinical experience, the syndrome of @<m>DISEASE_Kidney_Neoplasms</m> @DISEASE_MESH:D007680 @@@kidney yin deficiency@@@ is a common type of @DISEASE_Diabetic_Nephropathies @DISEASE_MESH:D003928 @@@DKD@@@. ", "citations": {"NLM": "Liao T, Zhao K, Huang Q, Tang S, Chen K, Xie C, Zhang C, Gan W. A randomized controlled clinical trial study protocol of Liuwei Dihuang pills in the adjuvant treatment of diabetic kidney disease Medicine (Baltimore). 2020 Jul 31;99(31):e21137. PMID: 32756091", "BibTeX": "@article{32756091, title={A randomized controlled clinical trial study protocol of Liuwei Dihuang pills in the adjuvant treatment of diabetic kidney disease}, author={Liao T and Zhao K and Huang Q and Tang S and Chen K and Xie C and Zhang C and Gan W}, journal={Medicine (Baltimore)}, volume={99}, number={31}, pages={e21137}}"}}, {"_id": "28045889", "pmid": 28045889, "pmcid": "PMC5226302", "title": "Metformin Induces Growth Inhibition and Cell Cycle Arrest by Upregulating MicroRNA34a in Renal Cancer Cells", "journal": "Med Sci Monit", "authors": ["Xie W", "Wang L", "Sheng H", "Qiu J", "Zhang D", "Zhang L", "Yang F", "Tang D", "Zhang K"], "date": "2017-01-03T00:00:00Z", "doi": "10.12659/msm.898710", "meta_date_publication": "2017 Jan 3", "meta_volume": "23", "meta_issue": "", "meta_pages": "29-37", "score": 50083.285, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Induces Growth Inhibition and Cell Cycle Arrest by Upregulating @GENE_MIR34A @GENE_407040 @@@MicroRNA34a@@@ in @<m>DISEASE_Kidney_Neoplasms</m> @DISEASE_MESH:D007680 @@@Renal Cancer@@@ Cells", "citations": {"NLM": "Xie W, Wang L, Sheng H, Qiu J, Zhang D, Zhang L, Yang F, Tang D, Zhang K. Metformin Induces Growth Inhibition and Cell Cycle Arrest by Upregulating MicroRNA34a in Renal Cancer Cells Med Sci Monit. 2017 Jan 3;23():29-37. PMID: 28045889", "BibTeX": "@article{28045889, title={Metformin Induces Growth Inhibition and Cell Cycle Arrest by Upregulating MicroRNA34a in Renal Cancer Cells}, author={Xie W and Wang L and Sheng H and Qiu J and Zhang D and Zhang L and Yang F and Tang D and Zhang K}, journal={Med Sci Monit}, volume={23}, pages={29-37}}"}}]}